STK11 encodes the tumor suppressor liver kinase B1 (LKB1), which suppresses tumor growth, and its mutation occurs in approximately 30% of KRAS-mutant lung adenocarcinoma cases; this mutation can promote KRAS-driven cancer growth and early metastasis [7, 8]. Here, KRAS is linked to lung adenocarcinoma.